SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-008929
Filing Date
2019-06-10
Accepted
2019-06-10 16:01:28
Documents
72
Period of Report
2019-04-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 870002
2 ex10-1.htm EX-10.1 37438
3 ex31-1.htm EX-31.1 19027
4 ex31-2.htm EX-31.2 19040
5 ex32-1.htm EX-32.1 6658
6 ex32-2.htm EX-32.2 6665
7 image_001.jpg GRAPHIC 25278
  Complete submission text file 0001493152-19-008929.txt   4443681

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE adxs-20190430.xml EX-101.INS 864658
9 XBRL SCHEMA FILE adxs-20190430.xsd EX-101.SCH 42798
10 XBRL CALCULATION FILE adxs-20190430_cal.xml EX-101.CAL 66345
11 XBRL DEFINITION FILE adxs-20190430_def.xml EX-101.DEF 138272
12 XBRL LABEL FILE adxs-20190430_lab.xml EX-101.LAB 316689
13 XBRL PRESENTATION FILE adxs-20190430_pre.xml EX-101.PRE 255800
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 19888585
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1